NADAC acquisition cost data for MORPHINE SULFATE IR 30 MG TAB. This is a generic medication, typically more affordable than brand-name equivalents.
| Generic Name | morphine sulfate |
| Brand Name | Morphine sulfate |
| Manufacturer | Bryant Ranch Prepack |
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
| Route | ORAL |
| Pharmacologic Class | Opioid Agonist |
| Product Type | HUMAN PRESCRIPTION DRUG |
| DEA Schedule | CII |
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 00054023624 | $0.3243 | 2022-12-21 | Rx |
| 00054023625 | $0.3243 | 2022-12-21 | Rx |
| 00832027411 | $0.3243 | 2022-12-21 | Rx |
| 51862061701 | $0.3243 | 2022-12-21 | Rx |
| 67877067101 | $0.3243 | 2022-12-21 | Rx |
| 00054023624 | $0.3243 | 2022-12-21 | Rx |
| 00054023625 | $0.3243 | 2022-12-21 | Rx |
| 00832027411 | $0.3243 | 2022-12-21 | Rx |
| 51862061701 | $0.3243 | 2022-12-21 | Rx |
| 67877067101 | $0.3243 | 2022-12-21 | Rx |
Generic: Morphine Sulfate | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $103.4M | 2,601,723 | 324,094 | $0.6378 |
| 2020 | $91.2M | 2,455,197 | 294,152 | $0.5990 |
| 2021 | $90.7M | 2,263,182 | 276,326 | $0.6490 |
| 2022 | $83.0M | 2,105,843 | 260,878 | $0.6424 |
| 2023 | $66.1M | 2,003,652 | 255,247 | $0.5446 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.
Explore More Data Tools
For adjacent public-data tools, methodology notes, and network updates, visit DataPeek Facts.